BIOCRYST PHARMACEUTICALS INC (BCRX) Stock Earnings Estimates

USA • Nasdaq • NASDAQ:BCRX • US09058V1035

6.55 USD
+0.25 (+3.97%)
At close: Feb 10, 2026
6.55 USD
0 (0%)
After Hours: 2/10/2026, 8:00:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
BCRX revenue by date.BCRX revenue by date.
270.8M
72.26%
331.412M
22.38%
450.712M
36.00%
631.94M
40.21%
670.69M
6.13%
752.24M
12.16%
897.92M
19.37%
1.1B
22.51%
1.33B
20.91%
1.544B
16.09%
1.703B
10.30%
1.784B
4.76%
EBITDA
YoY % growth
BCRX ebitda by date.BCRX ebitda by date.
-146.96M
16.93%
-100.506M
31.61%
-1.297M
98.71%
97.92M
7,649.73%
82.61M
-15.64%
145.86M
76.56%
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
BCRX ebit by date.BCRX ebit by date.
-148.4M
16.49%
-102.161M
31.16%
-2.543M
97.51%
119.41M
4,795.64%
121.33M
1.61%
177.7M
46.46%
252.26M
41.96%
480.92M
90.64%
682.48M
41.91%
883.29M
29.42%
1.022B
15.70%
1.081B
5.77%
Operating Margin
BCRX operating margin by date.BCRX operating margin by date.
-54.80%-30.83%-0.56%18.90%18.09%23.62%28.09%43.72%51.31%57.21%60.01%60.59%
EPS
YoY % growth
BCRX eps by date.BCRX eps by date.
-1.33
-29.13%
-0.99
25.56%
-0.43
56.57%
0.18
142.70%
0.40
116.94%
0.54
36.28%
0.97
79.45%
1.60
64.40%
2.28
42.20%
2.95
29.68%
3.38
14.34%
3.35
-0.91%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
0.05
137.96%
0.070.10
137.99%
0.09
44.50%
0.10
103.25%
Revenue
Q2Q % growth
154.35M
17.35%
155.08M
6.56%
170.8M
4.56%
172.41M
8.17%
182.16M
18.02%
EBITDA
Q2Q % growth
14.545M
545.89%
N/AN/AN/AN/A
EBIT
Q2Q % growth
22.277M
594.17%
31.94M
50.47%
40.7M
36.64%
39.809M
34.53%
34.454M
54.66%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
0.06
185.71%
0.040.0267.02%
Q2 2025
Q2Q % growth
0.04
166.67%
0.010.03180.11%
Q1 2025
Q2Q % growth
0.00
100.00%
-0.070.07100.00%
Q4 2024
Q2Q % growth
-0.13
53.57%
-0.06-0.07-123.60%
Q3 2024
Q2Q % growth
-0.07
63.16%
-0.070.00-6.50%
Q2 2024
Q2Q % growth
-0.06
75.00%
-0.180.1266.23%
Q1 2024
Q2Q % growth
-0.17
39.29%
-0.220.0520.98%
Q4 2023
Q2Q % growth
-0.28
26.32%
-0.25-0.03-12.50%
Q3 2023
Q2Q % growth
-0.19
17.39%
-0.240.0520.19%
Q2 2023
Q2Q % growth
-0.24
25.00%
-0.23-0.01-3.06%
Q1 2023
Q2Q % growth
-0.28
30.00%
-0.300.028.14%
Q4 2022
Q2Q % growth
-0.38
-280.00%
-0.17-0.21-120.09%
Q3 2022
Q2Q % growth
-0.23
30.30%
-0.300.0722.47%
Q2 2022
Q2Q % growth
-0.32
-33.33%
-0.350.038.62%
Q1 2022
Q2Q % growth
-0.40
-11.11%
-0.37-0.03-7.10%
Q4 2021
Q2Q % growth
-0.10
70.59%
-0.310.2167.82%
Q3 2021
Q2Q % growth
-0.33
-26.92%
-0.30-0.03-9.92%
Q2 2021
Q2Q % growth
-0.24 -0.250.012.26%
Q1 2021
Q2Q % growth
-0.36
-50.00%
-0.28-0.08-29.80%
Q4 2020
Q2Q % growth
-0.34 -0.26-0.08-32.96%
Q3 2020
Q2Q % growth
-0.26 -0.260.000.16%
Q2 2020
Q2Q % growth
-0.24 -0.260.027.89%
Q1 2020
Q2Q % growth
-0.24 -0.250.013.04%
BCRX Yearly EPS VS EstimatesBCRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 1 -1 2 3
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
159.395M
36.14%
166.23M-6.835M-4.11%
Q2 2025
Q2Q % growth
163.353M
49.41%
152.73M10.623M6.96%
Q1 2025
Q2Q % growth
145.534M
56.89%
129.4M16.134M12.47%
Q4 2024
Q2Q % growth
131.534M
40.83%
132.75M-1.216M-0.92%
Q3 2024
Q2Q % growth
117.085M
34.98%
114.75M2.335M2.03%
Q2 2024
Q2Q % growth
109.332M
32.54%
100.29M9.042M9.02%
Q1 2024
Q2Q % growth
92.761M
34.87%
87.317M5.444M6.23%
Q4 2023
Q2Q % growth
93.401M
17.41%
91.807M1.594M1.74%
Q3 2023
Q2Q % growth
86.742M
14.39%
87.673M-931K-1.06%
Q2 2023
Q2Q % growth
82.491M
25.88%
82.606M-115K-0.14%
Q1 2023
Q2Q % growth
68.778M
37.78%
73.111M-4.333M-5.93%
Q4 2022
Q2Q % growth
79.55M
68.68%
77.149M2.401M3.11%
Q3 2022
Q2Q % growth
75.83M
85.00%
76.117M-287K-0.38%
Q2 2022
Q2Q % growth
65.53M
31.16%
65.594M-64K-0.10%
Q1 2022
Q2Q % growth
49.92M
161.91%
52.387M-2.467M-4.71%
Q4 2021
Q2Q % growth
47.16M
1,073.13%
50.53M-3.37M-6.67%
Q3 2021
Q2Q % growth
40.99M
571.97%
40.885M105K0.26%
Q2 2021
Q2Q % growth
49.96M
1,640.77%
29.245M20.715M70.83%
Q1 2021
Q2Q % growth
19.06M
295.44%
9.067M9.993M110.21%
Q4 2020
Q2Q % growth
4.02M 15.038M-11.018M-73.27%
Q3 2020
Q2Q % growth
6.1M 3.677M2.423M65.90%
Q2 2020
Q2Q % growth
2.87M 2.301M569K24.73%
Q1 2020
Q2Q % growth
4.82M 4.376M444K10.15%
BCRX Yearly Revenue VS EstimatesBCRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS38.7% 40.93% 8.6% 108.38%
Revenue0.7% -0.11% 0.16% -0.96%